Anthony Hall Email & Phone Number

United Kingdom

Cambridge, Cambridgeshire, Gb

Findacure is a charity with the mission to build a movement to promote research and development of treatments for fundamental diseases on behalf of patients and those who care for them. We do this by: ● Empowering patient groups to evolve into effective campaigners for change. ● Facilitating patient groups to drive the development of treatments for fundamental diseases. ● Campaigning for a receptive research environment that recognises the pivotal importance of fundamental diseases. In undertaking our mission, Findacure follows in the footsteps of William Bateson, the father of modern genetics, who reminded us that it is worthwhile to "treasure our exceptions". Fundamental diseases are extreme and rare genetic disorders, which offer a unique opportunity to better understand other diseases, including many common conditions. We have coined this term in order to emphasise the fact that rare diseases are relevant for everyone, not only those people who are affected by them. This paradigm is more relevant today than ever, but has been recognised for centuries, as exemplified by this quote from Dr William Harvey in 1657: “There is no better way to advance the proper practice of medicine than to give our minds to the discovery of the usual law of nature by the careful investigation of cases of rarer forms of disease.”

Sirgartan believes that mental illness should no longer be underestimated and stigmatised. Sirgartan Therapeutics is a drug development company established in 2020 and poised to enter the clinic in 2024. Our vision is to transform the treatment paradigm for OCD (obsessive compulsive disorder) and deliver life-changing medicines for patients with this condition, many of whom are very poorly treated with current therapies.The company is working with the University of Cambridge, UK on a first-in-class treatment based on modulation of glutamate. The development asset was recently taken to clinical trials for another condition, but then discontinued due to lack of efficacy in that condition, leaving Sirgartan able to use the existing information to shortcut entry into clinical trials for OCD.Investment obtained through initial seed-funding has enabled advanced pre-clinical studies to be carried out by the University of Cambridge. These studies have shown very encouraging results in an animal model of OCD, much to the satisfaction of Professor Trevor Robbins, Chief Scientific Advisor to Sirgartan, and to the recent submission of a patent application for the identified therapy and its method of action.The company is now seeking further funding to enable progression into clinical studies. Please contact us should you or your organisation have an interest in joining us on this journey.

Cambridge, Cambridgeshire, Gb

London, Gb

Wrexham, Wales, Gb

Aparito links wearable devices with disease-specific mobile apps to provide remote patient monitoring outside of the hospital environment. This delivers meaningful, relevant, and real-time data between patients and clinicians in a way that actively supports and enhances diagnosis and treatment. This helps to support better patient outcomes, improve understanding of disease, and clinical trial outcomes, facilitating innovative drug development, particularly for rare (orphan) diseases and paediatrics.

An incredible 6-month round the world adventure.

London, Gb

Mereo has acquired a human anti-sclerostin monoclonal antibody, with the intention to develop it for the treatment of osteogenesis imperfecta (OI).I am responsible for all aspects of this development programme.

London, London, Gb

Hoofddorp, Nl

Hoofddorp, Nl

I was one of the founders of the company, which I ran for 8 years before stepping out of the day-to-day management in order to concentrate on the Findacure charity and my consultancy work.

• Recruit and lead a team of medics for the Neuromuscular business;• Accountability for the strategic planning and execution of clinical trial programmes;• Provide clinical expertise for the R&D projects under my care;• Serve as the Medical Monitor for clinical trials;• Collaborate with internal & external stakeholders to ensure successful implementation of projects;• Serve as medical and technical resource for clinical issues raised by internal and external collaborators, investigators, consultants and contract resources;• Participate in the pharmacovigilance process;• Participate in analysis and interpretation of interim and final study data.

I provide medical expertise to the global drug development process and commercial organization with an emphasis on late phase studies. I also provide a strategic lead to the label extension studies for drisapersen and direction and leadership to clinical project managers by acting as Medical Monitor.I work closely with commercial colleagues, providing medical input in preparation for launch and post marketing activities for drisapersen. This includes training of staff, advising on appropriate clinical trial activities, expanded access and registry studies, KOL interactions and visibility on the company booth at scientific meetings.I work closely with the patient advocacy staff, regularly being the company spokesperson at patient group meetings, helping to maintain our relationships with the patient community.

DCPrime develops dendritic cell-based vaccines for a broad range of cancer types, based on its unique, proprietary technology platform, DCOne™. This first-in-class platform combines the power of dendritic cell-based vaccines with the advantages of allogeneic stimulation of the immune system whilst bypassing the complex logistics of autologous DC vaccines. The company’s lead product DCP-001 is in Phase I/IIa in patients with Acute Myeloid Leukemia (AML). A Phase II efficacy study will start shortly. Several products for solid cancers are in preclinical development, using peptide loaded DCOne-based vaccines.

As the medical member of the European Project Team, I was responsible for the “hands-on” management of ongoing clinical trials and the design and implementation of new studies. I was involved in safety assessments, addressing questions from the regulatory authorities, the supervision of writing of clinical trial reports and the writing of Clinical Expert Reports.I was responsible for the conception and implementation of the clinical development plan for a combination product with the new device.

Ingelheim Am Rhein, Rhineland-Palatinate, De

An international role with global responsibility for all medical aspects of the product, from the clinical development planning to the overall safety of the product. I was responsible for medical support to regulatory, including the handling of questions from the regulatory authorities.I provided medical support to Corporate Marketing during the launch phase. This included helping to develop promotional material, product monographs and training manuals, manuscripts for publication, opinion leader support, presentation of product features at advisory board meetings and internal medico-marketing meetings.I developed a creative phase IV strategy and the supervised ongoing phase IIIb trials.I was also responsible for the clinical development plan for a fixed-dose combination product.

Ingelheim Am Rhein, Rhineland-Palatinate, De

Sole responsibility for all aspects of phase IV activities for cardiovascular products. Responsible for new strategies in phase IV development and implementation of the clinical trial programs. Conceived and set clinical trials in the areas of hypertension, angina and myocardial infarction. Took on several international roles as Medical Sub-Team member for lacidipine and international Team Member Medicine for dipyridamole.Involved in the development of opinion leader support in the areas of hypertension, myocardial infarction and stroke. Responsible for the medico-marketing input into the launch phase of a combination product, dipyridamole/aspirin, for secondary prevention of stroke. Also helped to develop pre-launch strategies with a thrombolytic for the treatment of acute ischaemic stroke.

Mb Bs, Medicine

Bsc Akc, Physiology & Pharmacology

Education record

Education record

Education record